ARCHIVES

FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Want To Know What Cancer Research Projects Are Going On? CRESPAC Can Describe More Than 5,000

January 2, 1976

Review Of DCCR Programs Uncovers Problems, Assigns Scores To Each

June 30, 1978

(8-page issue)

October 4, 2002

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974